FALLS CHURCH, Va.
, Oct. 4, 2019
/PRNewswire-PRWeb/ -- Medical Device Nonconforming Audit Findings Corrective Action That's Right for Your Company An FDAnews Webinar Tuesday, Oct. 15, 2019
, 1:30-3:00 p.m. EDT
Despite best efforts to the contrary, getting nonconformities from a notified body during an audit does happen. How best to respond?
Organizations will be under a strict deadline… under pressure … to find out the corrective plan isn't right.
There are better ways to address these nonconformities, and an expert with over three decades of experience in the medical device industry — Connie Hoy
, founder of Hoy & Associates Regulatory Consulting — is here to explain them in this informative webinar.
Using real-life examples that show appropriate versus inappropriate responses, Ms. Hoy will share how to:
- Analyze the criticality of the audit findings
- Avoid complicating the corrective actions and inadvertently overburdening organizations
- Prioritize plans by identifying corrections and corrective actions
- Write a sufficient corrective action and preventive action (CAPA) procedure
- Draft an appropriate response to the auditing agency
If one might be tasked with responding to a regulatory audit — or signing a name to one — this webinar is a must.
Interested in registering multiple sites? Call (888) 838-5578 in the U.S. or +1 (703) 538-7600 globally to learn about our special multisite discount.
Webinar Details: Medical Device Nonconforming Audit Findings Corrective Action That's Right for Your Company An FDAnews Webinar Tuesday, Oct. 15, 2019
, 1:30-3:00 p.m. EDT
Easy Ways to Register: Online: https://www.fdanews.com/mdnonaudit
By phone: 888-838-5578 or 703-538-7600
About FDAnews: FDAnews is the premier provider of domestic and international regulatory, legislative, and business news and information for executives in industries regulated by the US FDA and the European Medicines Agency. Pharmaceutical and medical device professionals rely on FDAnews' print and electronic newsletters, books and conferences to stay in compliance with international standards and the FDA's complex and ever-changing regulations.